{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:05:20Z","timestamp":1767978320712,"version":"3.49.0"},"reference-count":24,"publisher":"Termedia Sp. z.o.o.","issue":"1","license":[{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"},{"start":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T00:00:00Z","timestamp":1677456000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cent Eur J Immunol"],"abstract":"<jats:p>The coronavirus disease 2019 pandemic is an ongoing concern for medical care worldwide. Since its emergence, multiple COVID-19 vaccines have been designed, allowing for more effective control of the pandemic. COVID-19 vaccines, like any other form of medical intervention, may cause adverse and unforeseen side effects, varying in frequency and severity. Determining a correlation between the occurring symptoms and the vaccination is often a challenging task, requiring multiple data sources and reported cases. So far, there have been multiple reports of trigeminal neuralgia developing after COVID-19 vaccination. A 36-year-old woman was admitted to the Emergency Ward due to chronic pain attacks in the left side of her face. The pain appeared two months ago, on the day following the vaccination using the third dose of the Pfizer BioNTech COVID-19 vaccine. At the Neurology Department she was diagnosed with trigeminal neuralgia. Based on the lack of any obvious causes, relation to the vaccination, and other similar reports, we assumed that the trigeminal neuralgia was a complication of the vaccination. Hospital treatment consisted of oxcarbazepine, dexamethasone and pregabalin. Treatment was successful, with transient episodes of exacerbation. Six months after the onset of the disorder the patient remains without pain. We believe that the presented case supports the possibility of trigeminal neuralgia occurring in relation to the Pfizer BioNTech COVID-19 vaccine administration. Additional reports may further contribute to establishing a certain link.<\/jats:p>","DOI":"10.5114\/ceji.2023.125309","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T02:44:30Z","timestamp":1677725070000},"page":"75-80","source":"Crossref","is-referenced-by-count":4,"title":["Trigeminal neuralgia occurring after the\u00a0third dose of\u00a0Pfizer BioNTech COVID-19 vaccine. Complication or coincidence? \nAn illustrative case report and literature review"],"prefix":"10.5114","volume":"48","author":[{"given":"Kacper","family":"Chrostowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Piasecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Bielewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2023,2,27]]},"reference":[{"key":"ref-1537593","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.adaj.2016.02.014","article-title":"Prevalence of trigeminal neuralgia: A systematic review","volume":"147","author":"De Toledo IP","year":"2016","unstructured":"De Toledo IP, Conti R\u00e9us J, Fernandes M, et al. (2016): Prevalence of trigeminal neuralgia: A systematic review. J Am Dent Assoc 147: 570-576.e2.","journal-title":"J Am Dent Assoc"},{"key":"ref-1537594","first-page":"1","volume-title":"Cephalalgia","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018): The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38: 1-211.","edition":"3rd edition"},{"key":"ref-1537595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13365-021-01030-7","article-title":"A case of trigeminal neuralgia developing after a COVID-19 vaccination","volume":"28","author":"Kaya A","year":"2022","unstructured":"Kaya A, Kaya SY (2022): A case of trigeminal neuralgia developing after a COVID-19 vaccination. J Neurovirol 28: 181-182.","journal-title":"J Neurovirol"},{"key":"ref-1537596","doi-asserted-by":"crossref","first-page":"11795735221102747","DOI":"10.1177\/11795735221102747","article-title":"Central nervous system demyelination following COVID-19 mRNA-based vaccination: Two case reports and literature review","volume":"14","author":"Lee S","year":"2022","unstructured":"Lee S, Hor JY, Koh KL, Chia YK (2022): Central nervous system demyelination following COVID-19 mRNA-based vaccination: Two case reports and literature review. J Cent Nerv Syst Dis 14: 11795735221102747.","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref-1537597","doi-asserted-by":"crossref","first-page":"e242344","DOI":"10.1136\/bcr-2021-242344","article-title":"Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19","volume":"4","author":"Narasimhalu K","year":"2021","unstructured":"Narasimhalu K, Lee WC, Salkade PR, De Silva DA (2021): Trigeminal and cervical radiculitis after tozinameran vaccination against COVID-19. BMJ Case Rep 4: e242344.","journal-title":"BMJ Case Rep"},{"key":"ref-1537598","doi-asserted-by":"crossref","first-page":"CASE22101","DOI":"10.3171\/CASE22101","article-title":"Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case","volume":"3","author":"Onoda K","year":"2022","unstructured":"Onoda K, Sashida R, Fujiwara R, et al. (2022): Trigeminal neuropathy after tozinameran vaccination against COVID-19 in postmicrovascular decompression for trigeminal neuralgia: illustrative case. J Neurosurg Case Lessons 3: CASE22101.","journal-title":"J Neurosurg Case Lessons"},{"key":"ref-1537599","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/ene.13950","article-title":"European Academy of Neurology guideline on trigeminal neuralgia","volume":"26","author":"Bendtsen L","year":"2019","unstructured":"Bendtsen L, Zakrzewska JM, Abbott J, et al. (2019): European Academy of Neurology guideline on trigeminal neuralgia. Eur J Neurol 26: 831-849.","journal-title":"Eur J Neurol"},{"key":"ref-1537600","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/head.14075","article-title":"Trigeminal neuralgia as the sole neurological manifestation of COVID-19: A case report","volume":"61","author":"Molina-Gil J","year":"2021","unstructured":"Molina-Gil J, Gonz\u00e1lez-Fern\u00e1ndez L, Garc\u00eda-Cabo C (2021): Trigeminal neuralgia as the sole neurological manifestation of COVID-19: A case report. Headache 61: 560-562.","journal-title":"Headache"},{"key":"ref-1537601","doi-asserted-by":"crossref","first-page":"119882","DOI":"10.1016\/j.jns.2021.119882","article-title":"Trigeminal neuralgia post COVID-19: Preliminary report and clinical consideration","volume":"429","author":"Caggia E","year":"2021","unstructured":"Caggia E, Bongiorno J, Ventura M, et al. (2021): Trigeminal neuralgia post COVID-19: Preliminary report and clinical consideration. J Neurol Sci 429: 119882.","journal-title":"J Neurol Sci"},{"key":"ref-1537602","doi-asserted-by":"publisher","DOI":"10.1002\/lary.30333"},{"key":"ref-1537603","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/09273972.2021.2022718","article-title":"Isolated abducens nerve palsy due to COVID-19","volume":"30","author":"Bing\u00f6l Klzlltun\u00e7 P","year":"2022","unstructured":"Bing\u00f6l Klzlltun\u00e7 P, Seven MY, Atilla H (2022): Isolated abducens nerve palsy due to COVID-19. Strabismus 30: 35-37.","journal-title":"Strabismus"},{"key":"ref-1537604","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1111\/ene.14860","article-title":"Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: A systematic review and meta-analysis","volume":"28","author":"Palaiodimou L","year":"2021","unstructured":"Palaiodimou L, Stefanou MI, Katsanos AH, et al. (2021): Prevalence, clinical characteristics and outcomes of Guillain-Barr\u00e9 syndrome spectrum associated with COVID-19: A systematic review and meta-analysis. Eur J Neurol 28: 3517-3529.","journal-title":"Eur J Neurol"},{"key":"ref-1537605","volume-title":"StatPearls","author":"Shankar Kikkeri N","year":"2022","unstructured":"Shankar Kikkeri N, Nagalli S (2022): Trigeminal neuralgia. In: StatPearls. StatPearls Publishing."},{"key":"ref-1537606","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.3390\/ijms23073604","article-title":"The molecular basis and pathophysiology of trigeminal neuralgia","volume":"23","author":"Chen Q","year":"2022","unstructured":"Chen Q, Yi DI, Perez JNJ, et al. (2022): The molecular basis and pathophysiology of trigeminal neuralgia. Int J Mol Sci 23: 3604.","journal-title":"Int J Mol Sci"},{"key":"ref-1537607","doi-asserted-by":"crossref","first-page":"577765","DOI":"10.1016\/j.jneuroim.2021.577765","article-title":"A systematic review of cases of CNS demyelination following COVID-19 vaccination","volume":"362","author":"Ismail II","year":"2022","unstructured":"Ismail II, Salama S (2022): A systematic review of cases of CNS demyelination following COVID-19 vaccination. J Neuroimmunol 362: 577765.","journal-title":"J Neuroimmunol"},{"key":"ref-1537608","doi-asserted-by":"crossref","first-page":"1018785","DOI":"10.3389\/fneur.2022.1018785","article-title":"CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review","volume":"13","author":"Rinaldi V","year":"2022","unstructured":"Rinaldi V, Bellucci G, Buscarinu MC, et al. (2022): CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review. Front Neurol 13: 1018785.","journal-title":"Front Neurol"},{"key":"ref-1537609","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-021-04792-9","article-title":"SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis","volume":"41","author":"Velikova T","year":"2021","unstructured":"Velikova T, Georgiev T (2021): SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis. Rheumatol Int 41: 509-518.","journal-title":"Rheumatol Int"},{"key":"ref-1537610","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/tpj.2015.21","article-title":"The role of Toll-like receptor 4 polymorphisms in vaccine immune response","volume":"16","author":"Pellegrino P","year":"2016","unstructured":"Pellegrino P, Falvella FS, Cheli S, et al. (2016): The role of Toll-like receptor 4 polymorphisms in vaccine immune response. Pharmacogenomics J 16: 96-101.","journal-title":"Pharmacogenomics J"},{"key":"ref-1537611","article-title":"COVID-19 Vaccine Reactions & Adverse Events","author":"Pfizer-BioNTech","unstructured":"Pfizer-BioNTech. COVID-19 Vaccine Reactions & Adverse Events on www.cdc.gov."},{"key":"ref-1537612","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15585\/mmwr.mm7039e4","article-title":"Safety monitoring of an additional dose of COVID-19 vaccine\u2013United States, August 12-September 19, 2021","volume":"70","author":"Hause AM","year":"2021","unstructured":"Hause AM, Baggs J, Gee J, et al. (2021): Safety monitoring of an additional dose of COVID-19 vaccine\u2013United States, August 12-September 19, 2021. MMWR Morb Mortal Wkly Rep 70: 1379-1384.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref-1537613","doi-asserted-by":"crossref","first-page":"612747","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize prime\/boost vaccine strategies: trained immunity as a new player in the game","volume":"12","author":"Palgen JL","year":"2021","unstructured":"Palgen JL, Feraoun Y, Dzangu\u00e9-Tchoupou G, et al. (2021): Optimize prime\/boost vaccine strategies: trained immunity as a new player in the game. Front Immunol 12: 612747.","journal-title":"Front Immunol"},{"key":"ref-1537614","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40121-022-00753-2","article-title":"Durability of vaccine-induced and natural immunity against COVID-19: A narrative review","volume":"12","author":"Pooley N","year":"2023","unstructured":"Pooley N, Abdool Karim SS, Combadi\u00e8re B, et al. (2023): Durability of vaccine-induced and natural immunity against COVID-19: A narrative review. Infect Dis Ther 12: 367-387.","journal-title":"Infect Dis Ther"},{"key":"ref-1537615","doi-asserted-by":"crossref","first-page":"e24403","DOI":"10.1002\/jcla.24403","article-title":"Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis","volume":"36","author":"Mahdizade Ari M","year":"2022","unstructured":"Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, et al. (2022): Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis. J Clin Lab Anal 36: e24403.","journal-title":"J Clin Lab Anal"},{"key":"ref-1537616","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/0333102411411203","article-title":"Numbness matters: A clinical review of trigeminal neuropathy","volume":"31","author":"Smith JH","year":"2011","unstructured":"Smith JH, Cutrer FM (2011): Numbness matters: A clinical review of trigeminal neuropathy. Cephalalgia 31: 1131-1144.","journal-title":"Cephalalgia"}],"container-title":["Central European Journal of Immunology"],"original-title":[],"link":[{"URL":"https:\/\/ceji.termedia.pl\/pdf-160322-129623","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ceji.termedia.pl\/pdf-160322-129623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:31:48Z","timestamp":1767947508000},"score":1,"resource":{"primary":{"URL":"https:\/\/ceji.termedia.pl\/Trigeminal-neuralgia-occurring-after-the-third-dose-of-Pfizer-BioNTech-COVID-19-vaccine,160322,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,27]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["160322"],"URL":"https:\/\/doi.org\/10.5114\/ceji.2023.125309","relation":{},"ISSN":["1426-3912","1644-4124"],"issn-type":[{"value":"1426-3912","type":"print"},{"value":"1644-4124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,27]]}}}